Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

August 2013

New Prior Authorization Requirement for Six Medications 

For dates of service beginning October 15, 2013, Harvard Pilgrim is requiring prior authorization for the following medications: H.P. Acthar Gel, Aloxi, Emend, Anzemet, Xolair, and Yervoy. Prior authorization is necessary to ensure that use is reasonable and necessary, clinically appropriate, and supported by evidence-based literature.

To obtain a prior authorization, providers must submit the required written information and meet the criteria as specified in the Prior Authorization Medical Review Criteria for Aloxi, Anzemet, Emend, H.P. Acthar Gel, Xolair, or Yervoy.

When requesting prior authorization via HPHConnect for providers, please select the “Outpatient” tab and select “Pharmacy” in the “Requested Service” drop down menu to ensure that the request is processed properly.

Xolair and Acthar are also available through Harvard Pilgrim’s specialty pharmacy program, with ICore supplying Xolair and Curascript supplying Acthar. If you choose to obtain Xolair or Acthar from the specialty pharmacy program, the prior authorization request must be submitted to MedImpact, rather than Harvard Pilgrim. For more information, please visit the Pharmacy program’s prior authorization page.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version


Cardiac Medication Adherence Report Now Available

Reminder: Maintain Up-To-Date Panel Status Information


Intralesional Injection Procedures: No Prior Authorization Required

Medical Criteria for Electric and Myoelectric Prosthetics

TMS Now Covered with Prior Authorization

Continuous Glucose Monitoring Systems

New Prior Authorization Requirement for Six Medications

Gastric Emptying Payment Policy Update

P&T Committee Updates

Specialty Pharmacy Updates

Recognizing Postpartum Depression in the Primary Care Setting


Changes to HPHConnect New User Accounts

Qualitative Drug Screen Testing


Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,

Kristin Edmonston,
Production Coordinator